Trial intelligence / Profile preview

Istradefylline effect on striatal dopamine D2 receptor availability in healthy male volunteers

jRCTs031180131Completed

Sponsor
Grants-in-Aid for Scientific Research
Start
May 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial comparing Istradefylline with Placebo (2 arms). Primary endpoint: Striatal dopamine D2 receptor availability. Started May 2019; status: completed.

02

Drugs

Istradefylline

Beyond the preview

Go deeper on jRCTs031180131.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031180131.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call